Biopharmaceutical CMO And CRO Market Size, Share & Trends Report

Biopharmaceutical CMO And CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-500-7
  • Number of Pages: 180
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Content

Chapter 1 Research Methodology
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing
Chapter 2 Executive Summary
                   2.1 Biopharmaceutical CMO & CRO Market Outlook, 2017 - 2030
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
                   3.1 Penetration &Growth Prospect Mapping For Contract Manufacturing Service, 2018
                   3.2 Trend Analysis
                       3.2.1 Source trend
                       3.2.2 Service trend
                       3.2.3 Product trend
                       3.2.4 Regional trend
                   3.3 Biopharmaceutical CMO & CRO Market: Market Dynamics
                       3.3.1 Market driver analysis
                            3.3.1.1 Rising investment by CMOs for capacity expansion
                            3.3.1.2 Commercial success of biopharmaceuticals and consequent increased demand for the biopharmaceuticals
                            3.3.1.3 Robust biopharmaceuticals pipeline
                            3.3.1.4 Cost and time saving benefits offered by contract services
                       3.3.2 Market restraint analysis
                            3.3.2.1 Limited outsourcing amongst well-stablished biopharmaceutical manufacturer
                   3.4 Key Opportunity Analysis
                       3.4.1 Rising funds in biopharmaceutical indutry
                       3.4.2 Mergers & acquistion for facility expansion
                       3.4.2 Growing demand for protein therapeutics
                   3.5 Industry Analysis - Porter’s
                       3.5.1 Supplier Power: Substantial number of suppliers for bioprocessing equipment contributes to the low supplier power
                       3.5.2 Buyer Power: Fragmented nature of biopharmaceutical industry has led to moderate bargaining power of buyers
                       3.5.3 Substitution Threat: High due to presence of several big pharma companies
                       3.5.4 New Entrants Threat: Presence of established players coupled with need of adequate capacity results in moderate threat of new entrants
                       3.5.5 Competitive Rivalry: High due to fragmented nature of market
                   3.6 Biopharmaceuticals CMO & CRO-SWOT Analysis, By PEST
                       3.6.1 Political landscape
                       3.6.2 Economic landscape
                       3.6.3 Social landscape
                       3.6.4 Technology landscape
                   3.7 Biopharmaceuticals CMO & CRO Market: Company Share Analysis
                   3.8 Competitive Landscape
                       3.8.1 Strategy Framework
                       3.8.2 Company Categorization
                       3.8.3 New Entrants
                       3.8.4 Mature Players & Leaders
                   3.9 Trends In Biopharmaceutical Industry
                   3.10 R&D Landscape Of Biopharmaceuticals
                   3.11 Customer Relationship Management In Contract Manufacturing
                       3.11.1 Selection process of CMO
                       3.11.2 Operations and quality oversight of CMOs
Chapter 4 Biopharmaceuticals CMO & CRO Market: Source Estimates & Trend Analysis
                   4.1 Global Biopharmaceuticals CMO & CRO Market: Source Movement Analysis
                   4.2 Mammalian Source
                       4.2.1 Global mammalian source market, 2017 - 2030 (USD Million)
                   4.3 Non-mammalian Source
                       4.3.1 Global mammalian source market, 2017 - 2030 (USD Million)
Chapter 5 Biopharmaceuticals CMO & CRO Market: Service Estimates & Trend Analysis
                   5.1 Global Biopharmaceuticals CMO & CRO Market: Service Movement Analysis
                   5.2 Contract Manufacturing, by service
                       5.2.1 Global contract manufacturing market, 2017 - 2030 (USD Million)
                       5.2.2 Process development
                            5.2.2.1 Global process development market, 2017 - 2030 (USD Million)
                            5.2.2.2 Downstream processing
                                5.2.2.2.1 Global downstream processing market, 2017 - 2030 (USD Million)
                            5.2.2.3 Upstream processing
                                5.2.2.3.1 Global upstream processing market, 2017 - 2030 (USD Million)
                       5.2.3 Fill & finish operations
                            5.2.3.1 Global fill & finish operations market, 2017 - 2030 (USD Million)
                       5.2.4 Analytical & QC testing
                            5.2.4.1 Global analytical & QC testing market, 2017 - 2030 (USD Million)
                       5.2.5 Packaging
                            5.2.5.1 Global contract packaging market, 2017 - 2030 (USD Million)
                   5.3 Contract Research
                       5.3.1 Global contract research market, 2017 - 2030 (USD Million)
                       5.3.2 Oncology
                            5.3.2.1 Global oncology market, 2017 - 2030 (USD Million)
                       5.3.3 Inflammation & immunology
                            5.3.3.1 Global inflammation & immunology market, 2017 - 2030 (USD Million)
                       5.3.4 Cardiology
                            5.3.4.1 Global cardiology market, 2017 - 2030 (USD Million)
                       5.3.5 Neuroscience
                            5.3.5.1 Global neuroscience market, 2017 - 2030 (USD Million)
                       5.3.6 Others
                            5.3.6.1 Global other CRO services market, 2017 - 2030 (USD Million)
Chapter 6 Biopharmaceuticals CMO & CRO Market: Product Estimates & Trend Analysis
                   6.1 Global Biopharmaceuticals CMO & CRO Market: Product Movement Analysis
                   6.2 Biologics
                       6.2.1 Global biologics market, 2017 - 2030 (USD Million)
                       6.2.2 Monoclonal Antibodies
                            6.2.2.1 Global monoclonal antibodies market, 2017 - 2030 (USD Million)
                       6.2.3 Recombinant proteins
                            6.2.3.1 Global recombinant proteins market, 2017 - 2030 (USD Million)
                       6.2.4 Vaccines
                            6.2.4.1 Global vaccines market, 2017 - 2030 (USD Million)
                       6.2.5 Antisense, RNAi, & molecular therapy
                            6.2.5.1 Global antisense, RNAi, &molecular therapy market, 2017 - 2030 (USD Million)
                       6.2.6 Others
                            6.2.6.1 Global other product market, 2017 - 2030 (USD Million)
                   6.3 Biosimilars
                       6.3.1 Global biosimilars market, 2017 - 2030 (USD Million)
Chapter 7 Biopharmaceuticals CMO & CRO Market: Regional Estimates & Trend Analysis, by Service, Source, & Product
                   7.1 Biopharmaceuticals CMO & CRO Market Share By Region, 2021 & 2030
                   7.2 North America
                       7.2.1 North America Biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
                       7.2.2 U.S.
                            7.2.2.1 U.S. biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.2.2.2 U.S. biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.2.2.3 U.S. biopharmaceuticals CMO & CRO market, by products, 2017 - 2030 (USD Million)
                       7.2.3 Canada
                            7.2.3.1 Canada biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.2.3.2 Canada biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.2.3.3 Canada biopharmaceuticals CMO & CRO market, by products, 2017 - 2030 (USD Million)
                   7.3 Europe
                       7.3.1 Europe Biopharmaceuticals CMO & CRO market, 2018 - 2030 (USD Million)
                       7.3.2 UK
                           7.3.2.1 UK biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                           7.3.2.2 UK biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                           7.3.2.3 UK biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.3 Germany
                            7.3.3.1 Germany biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.3.3.2 Germany biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.3.3.3 Germany biopharmaceuticals CMO & CRO market, by products, 2017 - 2030 (USD Million)
                       7.3.4 France
                            7.3.4.1 France biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.3.4.2 France biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.3.4.3 France biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.5 Italy
                            7.3.5.1 Italy biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                            7.3.5.2 Italy biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                            7.3.5.3 Italy biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                       7.3.6 Spain
                            7.3.6.1 Spain biopharmaceuticals CMO & CRO market, by source, 2018 - 2030 (USD Million)
                            7.3.6.2 Spain biopharmaceuticals CMO & CRO market, by service, 2018 - 2030 (USD Million)
                            7.3.6.3 Spain biopharmaceuticals CMO & CRO market, by products, 2018 - 2030 (USD Million)
                   7.4 Asia Pacific
                       7.4.1 Asia Pacific biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
                       7.4.2 China
                            7.4.2.1 China biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.4.2.2 China biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.4.2.3 China biopharmaceuticals CMO & CRO market, by products, 2017 - 2030 (USD Million)
                       7.4.3 India
                            7.4.3.1 India biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.4.3.2 India biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.4.3.3 India biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.4 Japan
                            7.4.4.1 Japan biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.4.4.2 Japan biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.4.4.3 Japan biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.5 Australia
                            7.4.5.1 Australia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.4.5.2 Australia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.4.5.3 Australia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.4.6 South Korea
                            7.4.6.1 South Korea biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.4.6.2 South Korea biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.4.6.3 South Korea biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                   7.5 Latin America
                       7.5.1 Latin America biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
                       7.5.2 Brazil
                            7.5.2.1 Brazil biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.5.2.2 Brazil biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.5.2.3 Brazil biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.3 Mexico
                            7.5.3.1 Mexico biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.5.3.2 Mexico biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.5.3.3 Mexico biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.4 Colombia
                            7.5.4.1 Colombia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.5.4.2 Colombia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.5.4.3 Colombia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.5.5 Argentina
                            7.5.5.1 Argentina biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.5.5.2 Argentina biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.5.5.3 Argentina biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                   7.6 Middle East & Africa (MEA)
                       7.6.1 Middle East & Africa biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
                       7.6.2 South Africa
                            7.6.2.1 South Africa biopharmaceuticals CMO & CRO market, by source, 2017 - 2030 (USD Million)
                            7.6.2.2 South Africa biopharmaceuticals CMO & CRO market, by service, 2017 - 2030 (USD Million)
                            7.6.2.3 South Africa biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.6.3 Saudi Arabia
                            7.6.3.1 Saudi Arabia biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.6.3.2 Saudi Arabia biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.6.3.3 Saudi Arabia biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
                       7.6.4 UAE
                            7.6.4.1 UAE biopharmaceuticals CMO & CRO market, by source, 2018-2030 (USD Million)
                            7.6.4.2 UAE biopharmaceuticals CMO & CRO market, by service, 2018-2030 (USD Million)
                            7.6.4.3 UAE biopharmaceuticals CMO & CRO market, by products, 2018-2030 (USD Million)
Chapter 8 Competitive Landscape
                   8.1 Company Profiles
                       8.1.1 Boehringer Ingelheim GmbH
                            8.1.1.1 Company overview
                            8.1.1.2 Financial performance
                            8.1.1.3 Product benchmarking
                            8.1.1.4 Strategic initiatives
                       8.1.2 LONZA
                            8.1.2.1 Company overview
                            8.1.2.2 Financial performance
                            8.1.2.3 Product benchmarking
                            8.1.2.4 Strategic initiatives
                       8.1.3 Inno Biologics Sdn Bhd
                            8.1.3.1 Company overview
                            8.1.3.2 Financial performance
                            8.1.3.3 Product benchmarking
                            8.1.3.4 Strategic initiatives
                       8.1.4 Rentschler Biotechnologie GmbH
                            8.1.4.1 Company overview
                            8.1.4.2 Financial performance
                            8.1.4.3 Product benchmarking
                            8.1.4.4 Strategic initiatives
                       8.1.5 JRS PHARMA
                            8.1.5.1 Company overview
                                8.1.5.1.1 CELONIC AG
                            8.1.5.2 Financial performance
                                8.1.5.2.1 Financial performance
                            8.1.5.3 Product benchmarking
                            8.1.5.4 Strategic initiatives
                       8.1.6 BIOMEVA GmbH
                            8.1.6.1 Company overview
                            8.1.6.2 Financial performance
                            8.1.6.3 Product benchmarking
                            8.1.6.4 Strategic initiatives
                       8.1.7 ProBioGen
                            8.1.7.1 Company overview
                            8.1.7.2 Financial performance
                            8.1.7.3 Product benchmarking
                            8.1.7.4 Strategic initiatives
                       8.1.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
                            8.1.8.1 Company overview
                            8.1.8.2 Financial performance
                            8.1.8.3 Product benchmarking
                            8.1.8.4 Strategic initiatives
                       8.1.9 TOYOBO CO., LTD.
                            8.1.9.1 Company overview
                            8.1.9.2 Financial performance
                            8.1.9.3 Product benchmarking
                            8.1.9.4 Strategic initiatives
                     8.1.10.4 Strategic initiatives
                       8.1.11 Patheon
                           8.1.11.1 Company overview
                               8.1.11.1.1 DPx
                           8.1.11.2 Financial performance
                           8.1.11.3 Product benchmarking
                           8.1.11.4 Strategic initiatives
                       8.1.12 CMC Biologics
                           8.1.12.1 Company overview
                           8.1.12.2 Financial performance
                           8.1.12.3 Product benchmarking
                           8.1.12.4 Strategic initiatives
                       8.1.13 Binex Co., Ltd.
                           8.1.13.1 Company overview
                           8.1.13.2 Financial performance
                           8.1.13.3 Product benchmarking
                           8.1.13.4 Strategic initiatives
                       8.1.14 WuXi Biologics
                           8.1.14.1 Company overview
                           8.1.14.2 Financial performance
                           8.1.14.3 Product benchmarking
                           8.1.14.4 Strategic initiatives
                       8.1.15 AbbVie, Inc.
                           8.1.15.1 Company overview
                           8.1.15.2 Financial performance
                           8.1.15.3 Product benchmarking
                           8.1.15.4 Strategic initiatives
                       8.1.16 Charles River Laboratories International, Inc
                           8.1.16.1 Company overview
                           8.1.16.2 Financial performance
                           8.1.16.3 Product benchmarking
                           8.1.16.4 Strategic initiatives
                       8.1.17 ICON plc.
                           8.1.17.1 Company overview
                           8.1.17.2 Financial performance
                           8.1.17.3 Product benchmarking
                           8.1.17.4 Strategic initiatives
                       8.1.18 LabCorp
                           8.1.18.1 Company overview
                           8.1.18.2 Financial performance
                           8.1.18.3 Product benchmarking
                           8.1.18.4 Strategic initiatives
                       8.1.19 Parexel International Corporation
                           8.1.19.1 Company overview
                           8.1.19.2 Financial performance
                           8.1.19.3 Product benchmarking
                           8.1.19.4 Strategic initiatives
                       8.1.20 PRA Health Sciences
                           8.1.20.1 Company overview
                           8.1.20.2 Financial performance
                           8.1.20.3 Product benchmarking
                           8.1.20.4 Strategic initiatives


List of Tables

TABLE 1 2020 pipeline of biologics
TABLE 2 Some commercially available biopharmaceuticals and biologics produced using both mammalian & non-mammalian cell lines
TABLE 3 Some commercially available biopharmaceuticals and biologics produced using only mammalian cell lines
TABLE 4 Some biopharmaceuticals produced using S. cerevisiae
TABLE 5 Some commercially available biopharmaceuticals and biologics produced using only microbial cell lines
TABLE 6 Some commercially available monoclonal antibody products
TABLE 7 Number of MAbs products by indication area, 2015
TABLE 8 Time and budget requirement for different stages of vaccine development
TABLE 9 North America biopharmaceuticals CMO & CRO market estimates, by source, 2017 - 2021 (USD Million)
TABLE 10 North America biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 11 North America biopharmaceuticals CMO & CRO market estimates, by service, 2017 - 2021 (USD Million)
TABLE 12 North America biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 13 North America biopharmaceuticals contract manufacturing market estimates, by service, 2017 - 2021 (USD Million)
TABLE 14 North America biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 15 North America biopharmaceuticals process development market estimates, by service, 2017 - 2021 (USD Million)
TABLE 16 North America biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 17 North America biopharmaceuticals contract research market estimates, by service, 2017 - 2021 (USD Million)
TABLE 18 North America biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 19 North America biopharmaceuticals CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 20 North America biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 21 North America biologics CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 22 North America biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 23 U.S. biopharmaceuticals CMO & CRO market estimates, by source, 2017 - 2021 (USD Million)
TABLE 24 U.S. biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 25 U.S. biopharmaceuticals CMO & CRO market estimates, by service, 2017 - 2021 (USD Million)
TABLE 26 U.S. biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 27 U.S. biopharmaceuticals contract manufacturing market estimates, by service, 2017 - 2021 (USD Million)
TABLE 28 U.S. biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 29 U.S. biopharmaceuticals process development market estimates, by service, 2017 - 2021 (USD Million)
TABLE 30 U.S. biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 31 U.S. biopharmaceuticals contract research market estimates, by service, 2017 - 2021 (USD Million)
TABLE 32 U.S. biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 33 U.S. biopharmaceuticals CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 34 U.S. biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 35 U.S. biologics CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 36 U.S. biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 37 Canada biopharmaceuticals CMO & CRO market estimates, by source, 2017 - 2021 (USD Million)
TABLE 38 Canada biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 39 Canada biopharmaceuticals CMO & CRO market estimates, by service, 2017 - 2021 (USD Million)
TABLE 40 Canada biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 41 Canada biopharmaceuticals contract manufacturing market estimates, by service, 2017 - 2021 (USD Million)
TABLE 42 Canada biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 43 Canada biopharmaceuticals process development market estimates, by service, 2017 - 2021 (USD Million)
TABLE 44 Canada biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 45 Canada biopharmaceuticals contract research market estimates, by service, 2017 - 2021 (USD Million)
TABLE 46 Canada biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 47 Canada biopharmaceuticals CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 48 Canada biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 49 Canada biologics CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 50 Canada biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 51 Europe biopharmaceuticals CMO & CRO market estimates, by source, 2017 - 2021 (USD Million)
TABLE 52 Europe biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 53 Europe biopharmaceuticals CMO & CRO market estimates, by service, 2017 - 2021 (USD Million)
TABLE 54 Europe biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 55 Europe biopharmaceuticals contract manufacturing market estimates, by service, 2017 - 2021 (USD Million)
TABLE 56 Europe biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 57 Europe biopharmaceuticals process development market estimates, by service, 2017 - 2021 (USD Million)
TABLE 58 Europe biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 59 Europe biopharmaceuticals contract research market estimates, by service, 2017 - 2021 (USD Million)
TABLE 60 Europe biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 61 Europe biopharmaceuticals CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 62 Europe biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 63 Europe biologics CMO & CRO market estimates, by product, 2017 - 2021 (USD Million)
TABLE 64 Europe biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 65 UK biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 66 UK biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 67 UK biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 68 UK biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 69 UK biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 70 UK biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 71 UK biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 72 UK biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 73 UK biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 74 UK biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 75 UK biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 76 UK biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 77 UK biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 78 UK biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 79 Germany biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 80 Germany biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 81 Germany biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 82 Germany biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 83 Germany biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 84 Germany biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 85 Germany biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 86 Germany biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 87 Germany biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 88 Germany biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 89 Germany biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 90 Germany biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 91 Germany biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 92 Germany biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 93 France biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 94 France biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 95 France biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 96 France biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 97 France biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 98 France biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 99 France biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 100 France biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 101 France biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 102 France biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 103 France biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 104 France biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 105 France biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 106 France biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 107 Italy biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 108 Italy biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 109 Italy biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 110 Italy biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 111 Italy biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 112 Italy biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 113 Italy biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 114 Italy biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 115 Italy biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 116 Italy biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 117 Italy biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 118 Italy biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 119 Italy biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 120 Italy biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 121 Spain biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 122 Spain biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 123 Spain biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 124 Spain biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 125 Spain biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 126 Spain biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 127 Spain biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 128 Spain biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 129 Spain biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 130 Spain biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 131 Spain biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 132 Spain biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 133 Spain biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 134 Spain biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 135 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 136 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 137 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 138 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 139 Asia Pacific biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 140 Asia Pacific biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 141 Asia Pacific biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 142 Asia Pacific biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 143 Asia Pacific biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 144 Asia Pacific biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 145 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 146 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 147 Asia Pacific biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 148 Asia Pacific biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 149 China biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 150 China biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 151 China biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 152 China biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 153 China biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 154 China biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 155 China biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 156 China biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 157 China biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 158 China biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 159 China biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 160 China biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 161 China biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 162 China biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 163 India biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 164 India biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 165 India biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 166 India biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 167 India biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 168 India biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 169 India biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 170 India biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 171 India biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 172 India biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 173 India biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 174 India biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 175 India biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 176 India biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 177 Japan biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 178 Japan biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 179 Japan biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 180 Japan biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 181 Japan biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 182 Japan biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 183 Japan biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 184 Japan biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 185 Japan biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 186 Japan biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 187 Japan biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 188 Japan biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 189 Japan biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 190 Japan biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 191 South Korea biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 192 South Korea biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 193 South Korea biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 194 South Korea biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 195 South Korea biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 196 South Korea biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 197 South Korea biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 198 South Korea biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 199 South Korea biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 200 South Korea biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 201 South Korea biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 202 South Korea biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 203 South Korea biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 204 South Korea biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 205 Australia biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 206 Australia biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 207 Australia biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 208 Australia biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 209 Australia biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 210 Australia biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 211 Australia biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 212 Australia biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 213 Australia biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 214 Australia biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 215 Australia biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 216 Australia biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 217 Australia biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 218 Australia biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 219 Latin America biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 220 Latin America biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 221 Latin America biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 222 Latin America biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 223 Latin America biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 224 Latin America biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 225 Latin America biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 226 Latin America biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 227 Latin America biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 228 Latin America biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 229 Latin America biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 230 Latin America biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 231 Latin America biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 232 Latin America biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 233 Brazil biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 234 Brazil biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 235 Brazil biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 236 Brazil biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 237 Brazil biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 238 Brazil biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 239 Brazil biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 240 Brazil biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 241 Brazil biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 242 Brazil biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 243 Brazil biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 244 Brazil biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 245 Brazil biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 246 Brazil biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 247 Mexico biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 248 Mexico biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 249 Mexico biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 250 Mexico biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 251 Mexico biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 252 Mexico biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 253 Mexico biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 254 Mexico biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 255 Mexico biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 256 Mexico biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 257 Mexico biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 258 Mexico biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 259 Mexico biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 260 Mexico biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 261 Colombia biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 262 Colombia biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 263 Colombia biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 264 Colombia biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 265 Colombia biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 266 Colombia biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 267 Colombia biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 268 Colombia biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 269 Colombia biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 270 Colombia biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 271 Colombia biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 272 Colombia biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 273 Colombia biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 274 Colombia biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 275 Argentina biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 276 Argentina biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 277 Argentina biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 278 Argentina biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 279 Argentina biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 280 Argentina biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 281 Argentina biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 282 Argentina biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 283 Argentina biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 284 Argentina biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 285 Argentina biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 286 Argentina biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 287 Argentina biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 288 Argentina biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 289 MEA biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 290 MEA biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 291 MEA biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 292 MEA biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 293 MEA biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 294 MEA biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 295 MEA biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 296 MEA biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 297 MEA biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 298 MEA biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 299 MEA biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 300 MEA biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 301 MEA biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 302 MEA biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 303 South Africa biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 304 South Africa biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 305 South Africa biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 306 South Africa biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 307 South Africa biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 308 South Africa biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 309 South Africa biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 310 South Africa biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 311 South Africa biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 312 South Africa biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 313 South Africa biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 314 South Africa biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 315 South Africa biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 316 South Africa biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 317 Saudi Arabia biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 318 Saudi Arabia biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 319 Saudi Arabia biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 320 Saudi Arabia biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 321 Saudi Arabia biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 322 Saudi Arabia biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 323 Saudi Arabia biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 324 Saudi Arabia biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 325 Saudi Arabia biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 326 Saudi Arabia biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 327 Saudi Arabia biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 328 Saudi Arabia biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 329 Saudi Arabia biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 330 Saudi Arabia biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 331 UAE biopharmaceuticals CMO & CRO market estimates, by source, 2018 - 2030 (USD Million)
TABLE 332 UAE biopharmaceuticals CMO & CRO market forecasts, by source, 2022 - 2030 (USD Million)
TABLE 333 UAE biopharmaceuticals CMO & CRO market estimates, by service, 2018 - 2030 (USD Million)
TABLE 334 UAE biopharmaceuticals CMO & CRO market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 335 UAE biopharmaceuticals contract manufacturing market estimates, by service, 2018 - 2030 (USD Million)
TABLE 336 UAE biopharmaceuticals contract manufacturing market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 337 UAE biopharmaceuticals process development market estimates, by service, 2018 - 2030 (USD Million)
TABLE 338 UAE biopharmaceuticals process development market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 339 UAE biopharmaceuticals contract research market estimates, by service, 2018 - 2030 (USD Million)
TABLE 340 UAE biopharmaceuticals contract research market forecasts, by service, 2022 - 2030 (USD Million)
TABLE 341 UAE biopharmaceuticals CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 342 UAE biopharmaceuticals CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)
TABLE 343 UAE biologics CMO & CRO market estimates, by product, 2018 - 2030 (USD Million)
TABLE 344 UAE biologics CMO & CRO market forecasts, by product, 2022 - 2030 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market segmentation & scope
FIG. 8 Biopharmaceutical CMO & CRO market outlook, 2017 - 2030
FIG. 9 Market trends & outlook
FIG. 10 Penetration & growth prospect mapping for contract manufacturing service, 2020
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Cumulative success rate comparison of biologics with small molecules over time
FIG. 13 Number of biologics investigational new drugs, 2005-2015
FIG. 14 Number of Reference Products by U.S. Biosimilars Launchable Dates
FIG. 15 Market restraint relevance analysis (Current & future impact)
FIG. 16 Risk associated with outsourcing services
FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 18 Porter’s Five Forces Analysis
FIG. 19 Company market share analysis
FIG. 20 Strategy framework
FIG. 21 Participant categorization
FIG. 22 CMO selection process
FIG. 23 Trends in biopharmaceutical industry
FIG. 24 R&D process of biopharmaceutical development
FIG. 25 Development phases where outsourcing partners are engaged
FIG. 26 Global biopharmaceuticals CMO & CRO market: Source outlook key takeaways
FIG. 27 Global Biopharmaceuticals CMO & CRO market: Source movement analysis
FIG. 28 Global mammalian source market, 2017 - 2030 (USD Million)
FIG. 29 Global mammalian source market, 2017 - 2030 (USD Million)
FIG. 30 Global biopharmaceuticals CMO & CRO market: Service type outlook key takeaways
FIG. 31 Global biopharmaceuticals CMO & CRO market: Service movement analysis
FIG. 32 Global contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 33 Percentage of biomanufacturers outsourcing some activity of upstream and downstream processing, 2011-2016
FIG. 34 Global process development market, 2017 - 2030 (USD Million)
FIG. 35 Global downstream processing market, 2017 - 2030 (USD Million)
FIG. 36 Global upstream processing market, 2017 - 2030 (USD Million)
FIG. 37 Global fill & finish operations market, 2017 - 2030 (USD Million)
FIG. 38 Global analytical & QC testing market, 2017 - 2030 (USD Million)
FIG. 39 Global contract packaging market, 2017 - 2030 (USD Million)
FIG. 40 Breakdown of the general CRO industry by type of service
FIG. 41 Initial attributes that play key role into CRO engagement
FIG. 42 Post-engagement attributes that play key role into CRO engagement
FIG. 43 Global contract research market, 2017 - 2030 (USD Million)
FIG. 44 Global oncology market, 2017 - 2030 (USD Million)
FIG. 45 Global inflammation & immunology market, 2017 - 2030 (USD Million)
FIG. 46 Global cardiology market, 2017 - 2030 (USD Million)
FIG. 47 Global neuroscience market, 2017 - 2030 (USD Million)
FIG. 48 Global other CRO services market, 2017 - 2030 (USD Million)
FIG. 49 Global biopharmaceuticals CMO & CRO market: Product outlook key takeaways
FIG. 50 Global biopharmaceuticals CMO & CRO market: Product movement analysis
FIG. 51 Global biologics market, 2017 - 2030 (USD Million)
FIG. 52 Year wise annual approvals for MAbs products which are currently marketed in U.S./EU
FIG. 53 Share of MAbs-related R&D programs at different pipeline phases, 2015
FIG. 54 Global monoclonal antibodies market, 2017 - 2030 (USD Million)
FIG. 55 Comparison of R&D biotech pipeline expansion for recombinant products
FIG. 56 Global recombinant proteins market, 2017 - 2030 (USD Million)
FIG. 57 Global vaccines market, 2017 - 2030 (USD Million)
FIG. 58 Global antisense, RNAi, &molecular therapy market, 2017 - 2030 (USD Million)
FIG. 59 Global other product market, 2017 - 2030 (USD Million)
FIG. 60 Global biosimilars market, 2017 - 2030 (USD Million)
FIG. 61 Regional market place: Key takeaway
FIG. 62 Comparison of biopharmaceutical manufacturing facilities region and country wise
FIG. 63 Biopharmaceuticals CMO & CRO regional outlook, 2020 & 2028
FIG. 64 North America biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
FIG. 65 Number of U.S. pharmaceutical outsourcing M&A transactions
FIG. 66 Biopharmaceuticals goods export growth comparison between 2011 and 2014
FIG. 67 U.S. biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
FIG. 68 Pros and cons of Canadian pharmaceutical & biopharmaceutical industry
FIG. 69 Canada biopharmaceuticals CMO & CRO market, 2017 - 2030 (USD Million)
FIG. 70 Europe biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 71 Revenue growth of Germany pharmaceutical industry
FIG. 72 UK biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 73 Germany biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 74 France biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 75 Italy biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 76 Spain biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 77 Factors supporting contract manufacturing/research in Asian countries
FIG. 78 Asia Pacific biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 79 China biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 80 India biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 81 Japan biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 82 South Korea biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 83 Australia biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 84 Latin America biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 85 Brazil biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 86 Mexico biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 87 Colombia biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 88 Argentina biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 89 Middle East & Africa biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 90 South Africa biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 91 Saudi Arabia biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)
FIG. 92 UAE biopharmaceuticals CMO & CRO market, 2018-2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.